Limbal squamous cell carcinoma in Haflinger horses.

The research article discusses the prevalence of Limbal Squamous Cell Carcinoma (LSCC) in the Haflinger breed of horses, and explores the potential genetic factors contributing to this breed’s susceptibility to LSCC.

Research Methodology

• The researchers studied a specific sample of 15 Haflinger horses, which had been diagnosed with LSCC. The affirmation of their breed was confirmed by the North American Haflinger Registry pedigree, and the diagnosis of LCCS was confirmed by a veterinary ophthalmologist or by histopathology.
• The research conducted a retrospective medical record review, focusing on the patient’s sex and age at diagnosis.
• For fifteen of the horses, a four-generation pedigree was available. The researchers used this information to analyze potential genetic inheritance patterns.

Research Findings

• The average age at diagnosis for the 19 Haflinger horses was 8.7 years, and the sample consisted of eleven males and eight females.
• Of the fifteen horses for which pedigrees were available, thirteen shared a common ancestor within five generations, and all fifteen were from the same ancestral A Stallion line.
• The researchers identified a common sire (male parental horse) for two of the affected horses. Despite this sire showing no signs or history of LSCC, the researchers proposed an autosomal recessive mode of inheritance.

Conclusions and Future Research

• The study findings suggest that Haflingers may be over-represented among horses with LSCC, and might receive a diagnosis at a younger age compared to other breeds.
• There appears to be a potential heritable basis for LSCC in Haflingers, given the close common ancestry among the affected horses.
• The researchers plan to further probe the LSCC genetic basis in Haflingers using a Genome-Wide Association Study (GWAS) approach. This process lends itself to identifying genetic variants in different individuals that are associated with a particular trait – in this case, susceptibility to LSCC.